Desempenho das variáveis clínicas e impacto da suplementação de ferro na identificação/prevenção da deficiência de ferro em doadores de sangue total da Fundação Hemoam
Carregando...
Arquivos
Data
Autores
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade do Estado do Amazonas
Resumo
Iron deficiency is a public health challenge, as it is the leading cause of
anemia worldwide, and blood donors are a susceptible group without an established
prevention protocol. It mainly affects blood donors of childbearing age, causing a higher
rate of unfitness and loss of donors. Objective: To evaluate the clinical variables and the
impact of iron supplementation on the identification/prevention of iron deficiency in
whole blood donors at the HEMOAM Foundation. Method: Randomized clinical trial
carried out at the Amazonas Hematology and Hemotherapy Foundation. Able-bodied
donos, aged 18 and over, were randomized into two supplementation groups, one with 40
mg of oral elemental iron on Mondays, Wednesdays and Fridays and the other weekly for
13 weeks. A third group was made up of donors who used less than 10% of the
supplementation. Sociodemographic, clinical and laboratory variables were collected on
the day the participants were recruited into the study and again after 90 days, when they
were evaluated. Results: 400 of 413 recruits were analyzed, the average age was 32 years,
131 (32,8 %) had iron deficiency with serum ferritin ≤ 30 ng/mL, of which 39 (9,5 %)
had ferritin below 15 ng/mL (complete absence of iron in stock). Deficiency was higher
in younger donors, as well as in frequent donors, particularly those with 3 or more
donations in the previous 2 years. After 90 days, 146 (35,4 %) donors returned for reevaluation.
118 (80,8 %) donors complied with iron supplementation and only 28,2 %
reported minor side effects. All hematimetric markers increased in both supplementation
protocols; however, only the iron-deficient group showed an increase of 3 ng/mL in serum
ferritin. Donors who received less than 10 % supplementation had a drop of 30 ng/mL in
serum ferritin and 2 donors developed iron deficiency. Conclusion: Iron deficiency is
very common among HEMOAM blood donors, particularly among those who donate
frequently. Iron supplementation was not enough to restore iron stores, although it did
increase hemoglobin levels and prevent the deterioration of iron stores